NO150280C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive 9-aminopyrido(1,2-a)pyrimidinderivater - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive 9-aminopyrido(1,2-a)pyrimidinderivater

Info

Publication number
NO150280C
NO150280C NO784392A NO784392A NO150280C NO 150280 C NO150280 C NO 150280C NO 784392 A NO784392 A NO 784392A NO 784392 A NO784392 A NO 784392A NO 150280 C NO150280 C NO 150280C
Authority
NO
Norway
Prior art keywords
aminopyrido
preparation
pyrimidine derivatives
therapeutic active
analogy procedure
Prior art date
Application number
NO784392A
Other languages
English (en)
Norwegian (no)
Other versions
NO150280B (no
NO784392L (no
Inventor
Istvan Hermecz
Zoltan Meszaros
Tibor Breining
Sandor Virag
Lelle Vasvari
Agnes Horvath
Gabor Nagy
Attila Mandi
Tamas Szuets
Istvan Bitter
Gyula Sebestyen
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of NO784392L publication Critical patent/NO784392L/no
Publication of NO150280B publication Critical patent/NO150280B/no
Publication of NO150280C publication Critical patent/NO150280C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO784392A 1977-12-29 1978-12-28 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 9-aminopyrido(1,2-a)pyrimidinderivater NO150280C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU77CI1795A HU180439B (en) 1977-12-29 1977-12-29 Process for producing 9-amino-pyrido-square bracket-1,2-a-square bracket closed-pyrimidine derivatives

Publications (3)

Publication Number Publication Date
NO784392L NO784392L (no) 1979-07-02
NO150280B NO150280B (no) 1984-06-12
NO150280C true NO150280C (no) 1984-09-19

Family

ID=10994684

Family Applications (1)

Application Number Title Priority Date Filing Date
NO784392A NO150280C (no) 1977-12-29 1978-12-28 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 9-aminopyrido(1,2-a)pyrimidinderivater

Country Status (28)

Country Link
US (1) US4260612A (fr)
JP (1) JPS54112895A (fr)
AR (1) AR221712A1 (fr)
AT (1) AT374476B (fr)
AU (1) AU520803B2 (fr)
BE (1) BE873141A (fr)
CA (1) CA1154766A (fr)
CH (1) CH641800A5 (fr)
CS (1) CS241014B2 (fr)
DD (1) DD143910A5 (fr)
DE (1) DE2854112A1 (fr)
DK (1) DK585478A (fr)
ES (1) ES476837A1 (fr)
FI (1) FI65620C (fr)
FR (1) FR2413390A1 (fr)
GB (1) GB2011408B (fr)
GR (1) GR67312B (fr)
HU (1) HU180439B (fr)
IL (1) IL56132A (fr)
IT (1) IT7869932A0 (fr)
LU (1) LU80659A1 (fr)
NL (1) NL7812479A (fr)
NO (1) NO150280C (fr)
PL (1) PL119517B1 (fr)
PT (1) PT68924A (fr)
SE (1) SE434056B (fr)
SU (1) SU906379A3 (fr)
YU (2) YU296378A (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU178452B (en) * 1979-05-11 1982-05-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing 9-substituted amino-4-oxo-6,7-dihydro-4h-pyrido/1,2-a/pyrimidine derivatives
HU183330B (en) * 1981-02-13 1984-04-28 Chinoin Gyogyszer Es Vegyeszet Process for producing new of 2,4,8-triazaphenalenium-salts
US5352795A (en) * 1986-03-07 1994-10-04 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
HU201551B (en) * 1988-02-03 1990-11-28 Chinoin Gyogyszer Es Vegyeszet Process for producing 4-oxo-4h-pyrido(1,2-a)pyrimidine-3-carboxylic acid amide derivatives and pharmaceutical compositions comprising same
US5252572A (en) * 1988-02-03 1993-10-12 Chinoin Gyogyszer- Es Vegyeszeti Termekek Gyara Rt. Pyridopyrimidine derivatives, pharmaceutical compositions containing them and process for preparing same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2786056A (en) * 1954-05-03 1957-03-19 Merck & Co Inc Acylamido-hydroxy pteridines and preparation thereof
GB1147759A (en) * 1965-06-17 1969-04-10 Sterling Drug Inc Aromatic derivatives and preparation thereof
CH538494A (de) * 1966-11-02 1973-06-30 Chinoin Gyogyszer Es Vegyeszet Verfahren zur Herstellung neuer Homopyrimidazol-Derivate
GB1141249A (en) * 1967-05-25 1969-01-29 Parke Davis & Co New quinazoline compounds and methods for their production
US3642797A (en) * 1968-06-10 1972-02-15 Sterling Drug Inc 4h-pyrido(1 2-a)pyrimidin-4-ones
JPS50149698A (fr) * 1974-05-25 1975-11-29
HU174693B (hu) * 1976-02-12 1980-03-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija kondensirovannykh proizvodnykh pirimidina
US4122274A (en) * 1977-05-25 1978-10-24 Bristol-Myers Company 3-Tetrazolo-5,6,7,8-substituted-pyrido[1,2-a]pyrimidin-4-ones

Also Published As

Publication number Publication date
CS909078A2 (en) 1985-06-13
FI65620B (fi) 1984-02-29
HU180439B (en) 1983-03-28
JPS54112895A (en) 1979-09-04
NO150280B (no) 1984-06-12
PL212205A1 (fr) 1980-02-25
ES476837A1 (es) 1979-06-16
PL119517B1 (en) 1982-01-30
CS241014B2 (en) 1986-03-13
SE7813225L (sv) 1979-06-30
YU296378A (en) 1983-10-31
LU80659A1 (de) 1979-04-13
AR221712A1 (es) 1981-03-13
GR67312B (fr) 1981-06-29
IT7869932A0 (it) 1978-12-22
SE434056B (sv) 1984-07-02
ATA901078A (de) 1983-09-15
FI784014A (fi) 1979-06-30
AU520803B2 (en) 1982-02-25
CH641800A5 (de) 1984-03-15
GB2011408B (en) 1982-06-30
IL56132A0 (en) 1979-03-12
AT374476B (de) 1984-04-25
PT68924A (en) 1979-01-01
NL7812479A (nl) 1979-07-03
NO784392L (no) 1979-07-02
CA1154766A (fr) 1983-10-04
IL56132A (en) 1982-02-28
FR2413390A1 (fr) 1979-07-27
DD143910A5 (de) 1980-09-17
FR2413390B1 (fr) 1982-06-11
AU4262878A (en) 1981-06-18
DK585478A (da) 1979-06-30
SU906379A3 (ru) 1982-02-15
YU278082A (en) 1983-10-31
DE2854112A1 (de) 1979-07-12
US4260612A (en) 1981-04-07
BE873141A (fr) 1979-04-17
FI65620C (fi) 1984-06-11
GB2011408A (en) 1979-07-11

Similar Documents

Publication Publication Date Title
NO149962C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater
NO156752B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(1-piperidinylalkyl)-4hpyrido(1,2-a)pyrimidin-4-0n derivater
NO157817C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive glycinamidderivater.
NO149102C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive trans-4-fenyl-1,2,3,4-tetrahydro-1-naftalenamin-derivater
NO153927C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 8-substituerte 4-amino-3-kinolinsyrederivater.
NO156611C (no) Analogifremgangsmaate for fremstilling av terapeutiske virksomme derivater av hydroksykarbonylfosfonsyre.
NO166320C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO156787C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO151287C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 9-hydrazono-6,7,8,9-tetrahydro-4h-pyrido(1,2-a)-pyrimidinderivater
NO146396C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidinderivater.
NO149065C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzodiazepinderivater
NO782756L (no) Fremgangsmaate for fremstilling av terapeutisk aktive antrakinonderivater
NO147564C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 5-benzyol-1,2-dihydro-3h-pyrrolo(1,2-a)pyrrol-1-karboksylsyrederivater
NO154054C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksypyrimidinderivater.
NO168037C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive purin-derivater.
DK330378A (da) Fremgangsmaade til fremstilling af terapeutisk aktive 6,7-dihydro-5h, 13h-chinazolino (3,2-a)-(1,4) benzodiazepin-5,13-dioner
NO153137C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte pyrido(1,2-a)pyrimidiner.
NO148454C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater
NO150158C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 6,7-dimetoksyquinazolinderivater
NO154795C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme 1,2,4-oxadiazolin-5-on-derivater.
NO150280C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 9-aminopyrido(1,2-a)pyrimidinderivater
NO149960C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive bis(nitrosoureido)-polyolderivater
NO794318L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive spiro-kinolyl-hydantoin-derivater
NO155773C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 3-substituerte tetrahydropyrrolo (1,2-a) pyrimidinderivater.
NO152556C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antracen-biskarbonylhydrazoner